Jade Biosciences, Inc.
JBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $75,743 | $595,885 | $717,032 | $287,798 |
| - Cash | $33,751 | $23,491 | $22,397 | $54,197 |
| + Debt | $108 | $675 | $1,090 | $574 |
| Enterprise Value | $42,099 | $573,069 | $695,725 | $234,175 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$282 | -$96 | -$68 | -$15 |
| % Margin | – | – | – | – |
| EBITDA | -$69,291 | -$75,369 | -$51,418 | -$22,945 |
| % Margin | – | – | – | – |
| Net Income | -$69,628 | -$75,521 | -$51,511 | -$22,963 |
| % Margin | – | – | – | – |
| EPS Diluted | -85.262 | -100.382 | -73.671 | -32.956 |
| % Growth | 15.1% | -36.3% | -123.5% | – |
| Operating Cash Flow | -$71,196 | -$56,778 | -$39,122 | -$27,399 |
| Capital Expenditures | $0 | -$142 | -$195 | -$181 |
| Free Cash Flow | -$71,196 | -$56,920 | -$39,317 | -$27,580 |